DAFNA Capital Management LLC
89 holdingsFiling period: 2026-06-30Current AUM: $468.7Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines Inc | 562.6K | $105.4M | $104.8M | 22.35% | -18,048 | 2026-06-30 |
| 2 | XBI | Spdr S&P Biotech ETF | 196.5K | $31.1M | $30.4M | 6.49% | -122,000 | 2026-06-30 |
| 3 | CMPS | Compass Pathways PLC | 2.01M | $28.5M | $23.8M | 5.07% | -406,930 | 2026-06-30 |
| 4 | STXS | Stereotaxis Inc | 13.68M | $23.5M | $14.1M | 3.01% | -- | 2026-06-30 |
| 5 | NKTR | Nektar Therapeutics | 318.4K | $22.2M | $12.1M | 2.58% | +153.2K | 2026-06-30 |
| 6 | DNLI | Denali Therapeutics Inc | 739.0K | $19.0M | $14.2M | 3.03% | +420.5K | 2026-06-30 |
| 7 | IDYA | Ideaya Biosciences Inc | 497.2K | $18.5M | $16.7M | 3.55% | +20.5K | 2026-06-30 |
| 8 | ATRC | Atricure Inc | 597.4K | $16.7M | $36.7M | 7.84% | -- | 2026-06-30 |
| 9 | XENE | Xenon Pharmaceuticals Inc | 250.8K | $15.1M | $9.0M | 1.93% | -- | 2026-06-30 |
| 10 | CYTK | Cytokinetics Inc | 172.0K | $14.7M | $10.6M | 2.26% | -45,499 | 2026-06-30 |
| 11 | RCUS | Arcus Biosciences Inc | 441.8K | $13.6M | $8.0M | 1.71% | -2,000 | 2026-06-30 |
| 12 | — | Ascendis Pharma A/S | 48.5K | $12.9M | $12.9M | 2.76% | -- | 2026-06-30 |
| 13 | NBIX | Neurocrine Biosciences Inc | 57.8K | $9.7M | $8.4M | 1.80% | -12,846 | 2026-06-30 |
| 14 | AXGN | Axogen Inc | 209.0K | $9.7M | $7.8M | 1.67% | -41,000 | 2026-06-30 |
| 15 | PODD | Insulet Corp | 61.9K | $9.4M | $9.3M | 1.98% | +51.0K | 2026-06-30 |
| 16 | EWTX | Edgewise Therapeutics Inc | 226.8K | $9.2M | $9.0M | 1.91% | +114.6K | 2026-06-30 |
| 17 | BCAX | Bicara Therapeutics Inc | 285.0K | $8.5M | $5.0M | 1.06% | -136,778 | 2026-06-30 |
| 18 | IBB | iShares NASDAQ Biotech Indx | 42.6K | $8.1M | $9.0M | 1.93% | -19,500 | 2026-06-30 |
| 19 | SNDX | Syndax Pharmaceuticals Inc | 335.3K | $7.3M | $4.6M | 0.98% | +117.9K | 2026-06-30 |
| 20 | MPLT | Maplight Therapeutics Inc | 171.0K | $6.1M | $1.4M | 0.30% | -- | 2026-06-30 |
| 21 | LRMR | Larimar Therapeutics Inc | 2.01M | $6.1M | $4.8M | 1.02% | -21,000 | 2026-06-30 |
| 22 | IPSC | Century Therapeutics Inc | 2.40M | $5.9M | $3.5M | 0.74% | -33,895 | 2026-06-30 |
| 23 | DXCM | Dexcom Inc | 86.3K | $5.8M | $6.8M | 1.45% | -- | 2026-06-30 |
| 24 | IMVT | Immunovant Inc | 149.5K | $5.8M | $4.3M | 0.92% | -1,000 | 2026-06-30 |
| 25 | INGN | Inogen Inc | 845.2K | $5.5M | $6.0M | 1.29% | -- | 2026-06-30 |
← Scroll →
Page 1 of 4